Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy

© 2021 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 33(2021), 45 vom: 06. Nov., Seite e2104779
1. Verfasser: Jiang, Tong (VerfasserIn)
Weitere Verfasser: Qiao, Yonghan, Ruan, Weimin, Zhang, Dongya, Yang, Qingshan, Wang, Guoying, Chen, Qunzhi, Zhu, Fengping, Yin, Jinlong, Zou, Yan, Qian, Rongjun, Zheng, Meng, Shi, Bingyang
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article cation-free glioblastoma micelle siRNA spherical nucleic acid Acrylic Resins Carbocyanines Cations Drug Carriers mehr... Micelles RNA, Small Interfering STAT3 Transcription Factor cyanine dye 5 poly-N-isopropylacrylamide 25189-55-3 Temozolomide YF1K15M17Y
LEADER 01000naa a22002652 4500
001 NLM332899934
003 DE-627
005 20231225220527.0
007 cr uuu---uuuuu
008 231225s2021 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202104779  |2 doi 
028 5 2 |a pubmed24n1109.xml 
035 |a (DE-627)NLM332899934 
035 |a (NLM)34751990 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Jiang, Tong  |e verfasserin  |4 aut 
245 1 0 |a Cation-Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 23.02.2022 
500 |a Date Revised 23.02.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2021 Wiley-VCH GmbH. 
520 |a Nanoparticle-based small interfering RNA (siRNA) therapy shows great promise for glioblastoma (GBM). However, charge associated toxicity and limited blood-brain-barrier (BBB) penetration remain significant challenges for siRNA delivery for GBM therapy. Herein, novel cation-free siRNA micelles, prepared by the self-assembly of siRNA-disulfide-poly(N-isopropylacrylamide) (siRNA-SS-PNIPAM) diblock copolymers, are prepared. The siRNA micelles not only display enhanced blood circulation time, superior cell take-up, and effective at-site siRNA release, but also achieve potent BBB penetration. Moreover, due to being non-cationic, these siRNA micelles exert no charge-associated toxicity. Notably, these desirable properties of this novel RNA interfering (RNAi) nanomedicine result in outstanding growth inhibition of orthotopic U87MG xenografts without causing adverse effects, achieving remarkably improved survival benefits. Moreover, as a novel type of polymeric micelle, the siRNA micelle displays effective drug loading ability. When utilizing temozolomide (TMZ) as a model loading drug, the siRNA micelle realizes effective synergistic therapy effect via targeting the key gene (signal transducers and activators of transcription 3, STAT3) in TMZ drug resistant pathways. The authors' results show that this siRNA micelle nanoparticle can serve as a robust and versatile drug codelivery platform, and RNAi nanomedicine and for effective GBM treatment 
650 4 |a Journal Article 
650 4 |a cation-free 
650 4 |a glioblastoma 
650 4 |a micelle 
650 4 |a siRNA 
650 4 |a spherical nucleic acid 
650 7 |a Acrylic Resins  |2 NLM 
650 7 |a Carbocyanines  |2 NLM 
650 7 |a Cations  |2 NLM 
650 7 |a Drug Carriers  |2 NLM 
650 7 |a Micelles  |2 NLM 
650 7 |a RNA, Small Interfering  |2 NLM 
650 7 |a STAT3 Transcription Factor  |2 NLM 
650 7 |a cyanine dye 5  |2 NLM 
650 7 |a poly-N-isopropylacrylamide  |2 NLM 
650 7 |a 25189-55-3  |2 NLM 
650 7 |a Temozolomide  |2 NLM 
650 7 |a YF1K15M17Y  |2 NLM 
700 1 |a Qiao, Yonghan  |e verfasserin  |4 aut 
700 1 |a Ruan, Weimin  |e verfasserin  |4 aut 
700 1 |a Zhang, Dongya  |e verfasserin  |4 aut 
700 1 |a Yang, Qingshan  |e verfasserin  |4 aut 
700 1 |a Wang, Guoying  |e verfasserin  |4 aut 
700 1 |a Chen, Qunzhi  |e verfasserin  |4 aut 
700 1 |a Zhu, Fengping  |e verfasserin  |4 aut 
700 1 |a Yin, Jinlong  |e verfasserin  |4 aut 
700 1 |a Zou, Yan  |e verfasserin  |4 aut 
700 1 |a Qian, Rongjun  |e verfasserin  |4 aut 
700 1 |a Zheng, Meng  |e verfasserin  |4 aut 
700 1 |a Shi, Bingyang  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 33(2021), 45 vom: 06. Nov., Seite e2104779  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:33  |g year:2021  |g number:45  |g day:06  |g month:11  |g pages:e2104779 
856 4 0 |u http://dx.doi.org/10.1002/adma.202104779  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 33  |j 2021  |e 45  |b 06  |c 11  |h e2104779